20-F: Jowell Global Ltd. Reports Fiscal Year 2024 Results: Revenue Declines Amidst Economic Headwinds

Sentiment:

Annual Results


Jowell Global Ltd. experienced a revenue decrease in fiscal year 2024, impacted by slower economic recovery and reduced consumer spending, while also reporting a material weakness in internal controls.

Worse than expectedThe company's revenue decreased by 16.9% compared to the previous year.

Summary

  • Jowell Global Ltd. reported a decrease in revenue for the fiscal year ended December 31, 2024, with total revenue declining to $132.98 million from $160.01 million in the previous year.
  • The company experienced a net loss of $8.00 million in 2024, compared to a net loss of $11.52 million in 2023.
  • Sales of cosmetic products decreased by 34.0%, while health and nutritional supplements sales increased by 48.5%.
  • Household product sales also saw a decrease of 23.3%.
  • The company identified a material weakness in its internal control over financial reporting related to a lack of sufficient accounting expertise.
  • The company's auditor, Enrome LLP, issued an unqualified opinion on the financial statements but noted a material uncertainty regarding the company's ability to continue as a going concern.
  • The company is taking steps to improve its financial performance and address the identified material weakness.

Sentiment

Score: 4

Explanation: The document presents a mixed sentiment. While the company improved its net loss, the overall financial performance was worse than the previous year, and there are concerns about internal controls and the ability to continue as a going concern.

Positives

  • The net loss decreased from $11.52 million in 2023 to $8.00 million in 2024.
  • Sales of health and nutritional supplements increased by 48.5%.
  • The company is taking steps to remediate the material weakness in internal control.

Negatives

  • Total revenue decreased by 16.9% to $132.98 million.
  • Cosmetic product sales declined by 34.0%.
  • Household product sales decreased by 23.3%.
  • The company identified a material weakness in its internal control over financial reporting.
  • The company's auditor expressed doubt about the company's ability to continue as a going concern.

Risks

  • The company's ability to continue as a going concern is uncertain.
  • The material weakness in internal control over financial reporting could lead to misstatements in financial reporting.
  • The company faces risks related to the interpretation and enforcement of Chinese laws and regulations.
  • The company's reliance on a VIE structure poses risks related to regulatory restrictions on foreign investment in China.
  • The company faces intense competition in the health and nutritional supplements and cosmetic markets in China.

Future Outlook

The company is implementing measures to improve financial performance and address the identified material weakness, but the recovery from the pandemic of overall economy in China has been slow and situation remains highly uncertain for any further outbreak or resurgence of the COVID-19 and new variants.

Industry Context

The report indicates that the company operates in a competitive market for health and nutritional supplements and cosmetic products in China, facing competition from both traditional retailers and online platforms.

Comparison to Industry Standards

  • The document does not provide specific comparisons to industry standards or competitors.
  • The document does not provide specific details about the performance of competitors or industry benchmarks.

Related Party Transactions

  • The company had significant related party transactions with Longrich Group and its subsidiaries, including purchases and operating leases.
  • The company had related party sales with Longrich America Intl, Inc.

Stakeholder Impact

  • Shareholders may be concerned about the company's declining revenue and net loss.
  • Employees may be affected by the company's cost-cutting measures.
  • Customers may be affected by changes in product offerings and pricing.

Next Steps

  • The company will hire accountants with extensive experience in US GAAP and SEC reporting.
  • The company will continue to closely monitor the COVID-19 situation.
  • The company will continue to develop its intelligent shopping method.
  • The company will continue to develop additional authorized physical stores.

Key Dates

DateDescription
2019-08-16Jowell Global Ltd. incorporated in the Cayman Islands
2019-11-01Reorganization of legal structure completed
2021-03-17Ordinary shares began trading on the Nasdaq Capital Market
2021-03-19Initial public offering (IPO) closed
2021-03-23Underwriter exercised over-allotment option
2021-07-27Shanghai Juhao entered into a Capital Increase Agreement with Suzhou Industrial Park Hongrun Rural Small Amount Loan Co., Ltd.
2022-06-13Company entered into securities purchase agreements with six investors
2022-10-11Company entered into a securities purchase agreement with five purchasers
2022-12-15Lu Qian appointed as Chief Financial Officer
2023-03-01Haiting Li appointed as Chairman and CEO
2023-10-25Shareholders approved share consolidation and share capital increase
2024-09-05Shanghai Jowell incorporated Baotou Juhaoyuan Trading Co., Ltd.
2024-12-31End of fiscal year 2024
2025-05-09Date of report

Keywords

Jowell Global, financial results, revenue, net loss, internal control, material weakness, going concern, cosmetics, health supplements, household products, China, e-commerce

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.